Sai Life Sciences IPO GMP: Subscription BEGINS
Sai Life Sciences IPO fully subscribed on second day of bidding; Retail portion booked only 30%
The Qualified Institutional Buyers (QIBs) booked their quota 2.88 times even as the investors in other categories adopted a cautious approach. The portion reserved for retail investors was booked 30% whereas the Non-Institutional Investors (NIIs) booked 28% of the shares set aside for them.
4h
Ireland’s economic success is due in no small part to the life sciences sector, but the challenge now is how to maintain a ...
Three-quarters of pharma and life sciences executives said they were optimistic for 2025, even though they expect some level ...
Valuations of life sciences businesses declined in the wake of the global pandemic, but government stimulus and medical ...
2don MSN
Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital. Dimension ...
In an exclusive interview, an expert in Unispace's Life Sciences growth strategy across the Americas, offers his perspective ...
The public issue of Sai Life Sciences kept its positive momentum on Day 2 of its subscription as well and saw 90% subscription so far on December 12 with qualified institutional buyers or QIBs ...
Valsoft Corporation Inc. (”Valsoft”), a Canadian company specializing in the acquisition and development of vertical market software businesses, has acquired Exeevo, a unified CRM solution for sales, ...
The proposed initial public offering includes a new issuance of equity shares amounting to ₹ 950 crore, along with an offer ...
Vishal Mega Mart, Mobikwik, and Sai Life Sciences—launched, offering investors a variety of choices. Vishal Mega Mart is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback